HOME   Cart(0)   Quotation   About-Us Policy PDFs Standard-List
www.ChineseStandard.net Database: 189759 (19 Oct 2025)

YY/T 1729-2020 English PDF

US$149.00 · In stock
Delivery: <= 3 days. True-PDF full-copy in English will be manually translated and delivered via email.
YY/T 1729-2020: (Fungus (1-3)-β-D glucan assay kit)
Status: Valid
Standard IDContents [version]USDSTEP2[PDF] delivered inStandard Title (Description)StatusPDF
YY/T 1729-2020English149 Add to Cart 3 days [Need to translate] (Fungus (1-3)-β-D glucan assay kit) Valid YY/T 1729-2020

PDF similar to YY/T 1729-2020


Standard similar to YY/T 1729-2020

YY/T 1713   YY/T 1709   YY/T 1721   YY/T 1735   YY/T 1728   

Basic data

Standard ID YY/T 1729-2020 (YY/T1729-2020)
Description (Translated English) (Fungus (1-3)-��-D glucan assay kit)
Sector / Industry Medical Device & Pharmaceutical Industry Standard (Recommended)
Classification of Chinese Standard C44
Word Count Estimation 8,857
Date of Issue 2020-06-30
Date of Implementation 2021-06-01
Regulation (derived from) Announcement No. 76 (2020) of the National Medical Products Administration
Issuing agency(ies) State Drug Administration

YY/T 1729-2020: (Fungus (1-3)-β-D glucan assay kit)

---This is a DRAFT version for illustration, not a final translation. Full copy of true-PDF in English version (including equations, symbols, images, flow-chart, tables, and figures etc.) will be manually/carefully translated upon your order.
People's Republic of China Pharmaceutical Industry Standards Released on 2020-06-30 Implementation of 2021-06-01 Issued by the National Medical Products Administration

Foreword

This standard was drafted in accordance with the rules given in GB/T 1.1-2009. Please note that some of the contents of this document may involve patents. Publication of this document The agency is not responsible for identifying these patents. This standard was proposed by the State Drug Administration. This standard is under the jurisdiction of the National Medical Clinical Laboratory and In Vitro Diagnostic System Standardization Technical Committee (SAC/TC136). Drafting organizations of this standard. Beijing Jinshanchuan Technology Development Co., Ltd., Beijing Medical Device Inspection Institute, Beijing Medical Device Technical Review Evaluation Center, Clinical Laboratory Center of National Health Commission, Tianjin Sino Biomedical Co., Ltd. The main drafters of this standard. Hu Jihong, Yang Zhong, Sun Rong, Guo Lili, He Yongsheng, Yuan Qinghua, Zang Danrong. Fungus (1-3)-β-D glucan determination kit

1 Scope

This standard specifies the requirements, test methods, identification, labeling and instructions for use, packaging, transportation and storage of the fungus (1-3)-β-D glucan determination kit. This standard applies to kits for the quantitative determination of fungal (1-3)-β-D glucan in human serum and plasma by spectrophotometry based on the principle of chromogenic matrix method.

2 Normative references

The following documents are indispensable for the application of this document. For dated reference documents, only the dated version applies to this article Pieces. For undated reference documents, the latest version (including all amendments) is applicable to this document. GB/T 29791.2 Information provided by manufacturers of in vitro diagnostic medical devices (labeling) Part 2.In vitro diagnostic reagents for professional use

3 requirements

3.1 Appearance Should meet the following requirements. a) The components of the kit should be complete, the inner and outer packaging should be complete, and the label should be clear; b) The liquid reagent has no leakage; the freeze-dried components are loose bodies, and the liquid has no visible particles or precipitation after reconstitution. 3.2 Quantity Should meet one of the following requirements. a) For single-serving liquid reagents that do not need to be extracted and directly added for testing, the deviation of the net content of the liquid reagent should not exceed ±5%; b) For multi-person liquid reagents, the net content of the liquid reagent should not be less than the labeled value. 3.3 Accuracy Should meet one of the following requirements. a) Relative deviation. should not exceed ±20%; b) Recovery rate. 80%~120%. 3.4 Linearity The manufacturer should specify the linear interval of the kit and meet the following requirements. a) The upper limit of the linear interval of the kit should not be lower than 500 pg/mL, and the lower limit should not be higher than 50 pg/mL; 3.5 Blank limit The blank limit should not be higher than 30 pg/mL. 3.6 Detection limit The detection limit should not be higher than 40pg/mL. 3.7 Repeatability Repeat the test for samples with at least two concentration levels, and the coefficient of variation of the results obtained should not be greater than 15%. 3.8 Difference between bottles within batch (dry powder or lyophilized reagent) There is no significant difference in the test values between 10 bottles of reagents in the same batch. 3.9 Difference between batches The difference between batches should not be more than 20%. 3.10 Analysis of specificity Preparation of common clinical concentration levels of endotoxin or gram-negative bacterial lipopolysaccharide as interfering substances, detection before and after adding interfering substances The absolute value of the concentration difference should not exceed the blank limit. 3.11 Stability You can choose one of the following methods for verification. a) Stability of validity period. The manufacturer shall stipulate the validity period of the kit. Take the kit within a certain period of time after the expiration date to test its accuracy Degree, linearity, blank limit, detection limit, repeatability, bottle-to-batch difference, analytical specificity, etc., should meet the requirements of 3.3~3.8 and 3.10; b) Thermal stability. take the kit within the validity period and place it at 37°C for a certain period of time to detect its accuracy, linearity, blank limit, and detection Limits, reproducibility, bottle-to-batch differences, analysis specificity, etc. should meet the requirements of 3.3 to 3.8 and 3.10. Note 1.Thermal stability cannot be used to derive the expiry date of the product, unless a derivation formula based on a large amount of stability research data is used; Note 2.Any combination of a) and b) methods can be selected according to product characteristics, but the selected method should be able to verify the stability of the product to ensure product performance within the validity period meet the standards.

4 Test method

4.1 Appearance Visual inspection with normal vision or corrected vision under natural light should meet the requirements of 3.1. 4.2 Quantity Measured with a universal measuring tool, it should meet the requirements of 3.2. 4.3 Accuracy It is recommended to use one of the following methods to test the accuracy of the kit according to the following priority order, which should meet the requirements of 3.3. a) Relative deviation The reagent (kit) test can be used to evaluate the certified reference material (CRM) or other recognized reference material of the conventional method for 3 times, according to formula (1) Calculate the relative deviation B (%). If all three results meet the requirements of 3.3a), it is deemed qualified. If the result of greater than or equal to 2 times is not If it meets, it is judged as unqualified. If there is one result that does not meet the requirements, the test should be repeated 20 times continuously, and the phases should be calculated according to formula (1). For the deviation, if the result of 19 tests meets the requirements of 3.3a), the accuracy meets the requirements of 3.3a). M --- test result; T --- Labeled value of certified reference material. b) Recovery test Add a certain volume of (1-3)-β-D glucan standard solution of known concentration to the negative sample matrix (the volume ratio between the added standard solution and the negative sample matrix should not be greater than 1.20, add the standard solution The concentration of the latter sample is near the critical value), and the test is repeated 3 times. root Calculate the recovery rate R according to formula (2), and the result should meet the requirements of 3.3b). Where. R ---Recovery rate; C --- The concentration of the negative sample matrix after adding the standard solution; V0 --- the volume of the negative sample matrix; V---the volume of the standard solution added; C0 --- The detection concentration of the negative sample matrix; CS ---The concentration of the standard solution. 4.4 Linearity Dilute the high-concentration sample close to the upper limit of the linear interval with a low-concentration sample close to the lower limit of the linear interval, and mix into at least 5 dilution concentrations 4.5 Blank limit Use the kit to test the blank sample (including buffer, etc.), repeat the test 20 times, get 20 measurement results, and calculate the average value (x) And the standard deviation (x), x + 2x should not be greater than the blank limit. 4.6 Detection limit The manufacturer shall provide relevant information such as the blank limit, detection limit and reference interval of the kit. According to the information provided by the manufacturer, The low-value samples with a degree similar to the detection limit are tested, and each sample is tested 5 times. The test results are sorted by size and meet the following conditions, namely It can be considered that the blank limit and detection limit provided by the manufacturer are basically reasonable, and the result should meet the requirements of 3.6. a) The number of test results lower than the blank limit value provided by the manufacturer should be less than or equal to 3; b) There is no value higher than the test result of the reference interval provided by the manufacturer. 4.7 Repeatability Use the kit to test samples with at least 2 concentration levels, repeat the test 10 times each, and calculate the average (x) and standard deviation of the measured values (S). Calculate the coefficient of variation (CV) according to formula (4), and the result should meet the requirements of 3.7. Where. CV---coefficient of variation; S --- the standard deviation of the results of 10 measurements; X --- the average of 10 measurements. The selection of the sample can refer to the critical value, which represents the normal value and the abnormal value level. Note. The normal value selects the detection concentration to be within the range of 30% lower than the critical value, and the abnormal value selects the detection concentration to be within the range of 30% higher than the critical value. 4.8 The difference between batches of bottles According to the specifications of the kit, test according to the following methods. a) Not applicable for single serving reagents; b) For multi-person reagents, 10 samples are taken, and each sample is tested 3 times under repeated conditions, taking into account factors such as the measurement system over time The random variation caused by the element, the 3 measurements are carried out in a different order, such as 1, 3, 5, 7, 9, 2, 4, 6, 8, 10, 10, 9, 8, 7, 6, 5, 4, 3, 2, 1, 2, 4, 6, 8, 10, 1, 3, 5, 7, 9.Calculate F according to formula (5) ~ formula (11), and the result should meet the requirements of 3.8. 4.9 Difference between batches Use 3 kits of different batch numbers to test samples near the critical value, and test each batch number 3 times, and calculate the average value of each batch of 3 tests. Claim. 4.10 Analysis of specificity Prepare endotoxin or gram-negative bacterial lipopolysaccharide at common clinical concentration levels as interfering substances, and calculate the before and after adding interfering substances Detect the absolute value of the concentration difference, and the result should meet the requirements of 3.10. 4.11 Stability The following methods can be used for verification. a) Stability of expiration date. test kits within a certain period of time after expiration date should be tested according to the methods of 4.3 to 4.8 and 4.10. 3.11a) requirements; b) Thermal stability test. take the kit within the validity period and place it at 37°C for a certain period of time, and proceed in accordance with the methods of 4.3 to 4.8 and 4.10 Testing should meet the requirements of 3.11b). 5 Marks, labels and instructions for use Should meet the requirements of GB/T 29791.2. 6 Packaging, transportation and storage 6.1 Packaging The packaging should meet the following requirements. a) The packaging of the kit should be able to protect it from natural and mechanical damage; b) If applicable, the instruction manual and product inspection certificate should be enclosed in the package, and the kit should be packaged according to the requirements of the manufacturer. 6.2 Transportation The kit should be transported according to the requirements of the manufacturer. 6.3 Storage The kit should be stored under the conditions specified by the manufacturer. references [1] GB/T 26124-2011 Clinical chemistry in vitro diagnostic reagents (kits) [2] GB/T 29791.1 Information provided by manufacturers of in vitro diagnostic medical devices (labeling) Part 1.Terms, definitions and communication Use requirements [3] YY/T 04666.1 Medical devices used in medical device labeling, marking and providing information symbols Part 1.General Claim

Tips & Frequently Asked Questions:

Question 1: How long will the true-PDF of YY/T 1729-2020_English be delivered?

Answer: Upon your order, we will start to translate YY/T 1729-2020_English as soon as possible, and keep you informed of the progress. The lead time is typically 1 ~ 3 working days. The lengthier the document the longer the lead time.

Question 2: Can I share the purchased PDF of YY/T 1729-2020_English with my colleagues?

Answer: Yes. The purchased PDF of YY/T 1729-2020_English will be deemed to be sold to your employer/organization who actually pays for it, including your colleagues and your employer's intranet.

Question 3: Does the price include tax/VAT?

Answer: Yes. Our tax invoice, downloaded/delivered in 9 seconds, includes all tax/VAT and complies with 100+ countries' tax regulations (tax exempted in 100+ countries) -- See Avoidance of Double Taxation Agreements (DTAs): List of DTAs signed between Singapore and 100+ countries

Question 4: Do you accept my currency other than USD?

Answer: Yes. If you need your currency to be printed on the invoice, please write an email to [email protected]. In 2 working-hours, we will create a special link for you to pay in any currencies. Otherwise, follow the normal steps: Add to Cart -- Checkout -- Select your currency to pay.